Dolomite Microfluidics
Develops the Fluidic Factory, the world's first commercial 3D printer for fabricating fluidically sealed microfluidic devices using COC polymer, enabling rapid prototyping of chips for as little as $1 per chip.
- CEO / Founder
- Mark Gilligan
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- £20M
- Latest Round
- Acquired
- Key Investors
- Maven Capital Partners; Oxford Sciences Innovation; MMC Ventures; Syncona
Technology & Products
Key Products
Fluidic Factory 3D printer; Microfluidic systems; Components (pumps, chips, connectors); Specialist chemicals for emulsion stabilization
Technological Advantage
Proprietary 3D printing process ensures water-tight, sealed fluidic paths in microfluidic devices, protected by being a first-mover in this niche (launched 2015). Advantage is replicable but defended by early market entry and specialized expertise in microfluidics.
Differentiation
Value Proposition
Reduces microfluidic chip prototyping cost to $1 per chip and enables rapid, on-demand fabrication of sealed devices, accelerating R&D timelines from weeks to days for drug development, diagnostics, and lab-on-a-chip applications.
How They Differentiate
3x faster prototyping than traditional microfluidic fabrication methods (molding, lithography) and 90% cost reduction per chip ($1 vs. $10+), with sealed devices ready-to-use without post-processing.
Market & Competition
Target Customers
Academic institutes, biotechs, start-ups, pharmaceutical companies, manufacturers, petrochemical companies, government institutes, and scientific organizations.
Industry Verticals
Biotechnology; Pharmaceutical; Medical; Research; Petrochemical
Competitors
Fluidic Factory (no direct named competitor found in microfluidics 3D printing niche); General microfluidics equipment providers (e.g., Dolomite's own traditional microfluidic systems)
Growth & Milestones
Growth Metrics
Grown year on year since 2005; thousands of customers in over 50 countries.
Major Milestones
Founded in 2005; Launched Fluidic Factory 3D printer in 2015; Celebrated 10 years of innovation in 2015; Partnerships for COVID-19 diagnostics and stem cell sorting
Notable Customers
Major academic institutes; Biotechs; Pharmaceutical companies; Government institutes; Mologic (for COVID-19 diagnostic tests)